z-logo
open-access-imgOpen Access
Antidotes for the new oral anticoagulant drugs!
Author(s) -
Jawed Fareed,
Fakiha Siddiqui,
Eduardo Ramacciotti,
Alfonso Tafur
Publication year - 2019
Publication title -
vascular investigation and therapy
Language(s) - English
Resource type - Journals
eISSN - 2589-9686
pISSN - 2589-9481
DOI - 10.4103/vit.vit_16_19
Subject(s) - antidote , apixaban , rivaroxaban , dabigatran , medicine , pharmacology , anticoagulant , human use , intensive care medicine , adverse effect , warfarin , oral anticoagulant , surgery , atrial fibrillation , microbiology and biotechnology , toxicity , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom